Specialty Pharmacy Certification Board forms
WASHINGTON — A new organization aims to be an independent group to certify specialty pharmacists.
The National Association of Specialty Pharmacy and the Specialty Pharmacy Certification Board each formed as the result of a decision to create an independent certification board. Originally, the certification board would have been an entity within a professional organization granted autonomy in making decisions regarding certification.
The SPCB said it was developing "unique and differentiated" certifications for pharmacists, nurses and pharmacy technicians to respond to unmet needs that have arisen as specialty pharmacy has grown, noting that there currently are fewer than 15,000 pharmacists certified by two other certification boards out of the more than 275,000 licensed pharmacists in the United States.
Pfizer, J&J drug appears ineffective in some Alzheimer’s patients
NEW YORK — An experimental drug under development by Pfizer and a unit of Johnson & Johnson does not appear effective in Alzheimer’s disease patients who carry a certain genotype, according to results of a late-stage clinical trial announced by Pfizer on Tuesday.
The company said, however, that the phase-3 Study 302 of bapineuzumab in patients with mild-to-moderate Alzheimer’s — who carry the apolipoprotein E epsilon 4, or ApoE4 genotype — was the first of four, and a study of patients who do not carry the genotype was ongoing, along with two others of patients who do. Patients in Study 302 no longer will receive doses of the drug, Pfizer said, but will receive further evaluations later on.
Pfizer is developing the drug with J&J subsidiary Janssen AI under the Alzheimer’s Immunotherapy Program, which also includes three other studies that are ongoing: Study 301 of noncarriers of ApoE4 and two additional studies of carriers, Study 3001 and Study 3000.
PepsiCo to sponsor Super Bowl XLVII Halftime Show
PURCHASE, N.Y. — PepsiCo and the National Football League have extended their multiyear partnership as Pepsi will sponsor the Super Bowl XLVII Halftime Show set for Feb. 3, 2013, in New Orleans.
The relationship between PepsiCo and the NFL marks an important extension of the company’s "Live for Now" campaign, which looks to capture the excitement of the moment and deliver experiences and content that is current in pop culture. What’s more, the announcement follows PepsiCo’s newly announced partnership with the Pittsburgh Steelers.
"Pepsi’s deep-rooted heritage with the Super Bowl and with music truly makes this relationship a natural fit," PepsiCo Beverages VP consumer engagement Adam Harter said. "As the most watched and highly-anticipated entertainment event of the year, the Super Bowl Halftime show is right at the heart of sports and music. We are excited to provide a fully integrated fan engagement experience for NFL and Pepsi fans."